Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taranabant in Overweight and Obese Patients With Type 2 Diabetes Mellitus
NCT00430742Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- Nov 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of taranabant in obesity, type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Nov 2006; status: terminated.
02
Drugs
taranabant
03
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00430742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430742.